 | | | | | | |
|---|
 | 2017 |
| |
| 01 |
| |
| | 01/23/2017 | 02:00 PM | | Merck KGaA, Darmstadt, Germany, Announces Research Collaboration with Domain Therapeutics in Immuno-Oncology |   | |
| | 01/19/2017 | 08:00 AM | | Innovation Award for Organic Photovoltaics at the BAU 2017 | | |
| | 01/18/2017 | 02:00 PM | | MilliporeSigma Launches First Commercial Service to Predict Multiple Sources of DNA Damage | | |
| | 01/17/2017 | 10:00 AM | | Merck KGaA, Darmstadt, Germany, Moves Executives Between Businesses and Group Functions | | |
| | 01/17/2017 | 02:00 PM | | MilliporeSigma Opens Production Facility Exclusively for Meglumine in Spain | | |
| | 01/13/2017 | 07:00 AM | | Merck KGaA, Darmstadt, Germany, Drives Business Opportunities in the U.S. to Foster Innovation Across all Three Business Sectors | | |
| | 01/13/2017 | 02:00 PM | | MilliporeSigma Introduces New Calibration Kit for In Vitro Diagnostic Use | | |
| | 01/12/2017 | 11:00 PM | | Merck KGaA, Darmstadt, Germany, and Palantir Launch New Healthcare Acceleration Partnership | | |
| | 01/11/2017 | 03:00 PM | | Merck KGaA, Darmstadt, Germany, Licenses Four Oncology Research and Development Programs from Vertex and Becomes a Leader in DNA Damage and Repair | | |
| | 01/10/2017 | 08:00 AM | | Merck KGaA, Darmstadt, Germany and CLEARink Displays Sign Development Agreement | | |
| | 01/10/2017 | 02:00 PM | | MilliporeSigma Expands End-to-End Biodevelopment Centers in North America, China and Europe | | |
| | 01/09/2017 | 02:00 PM | | EMD Serono and MD Anderson Cancer Center Enter Three-Year Strategic Collaboration | | |
| | 01/04/2017 | 02:30 PM | | MilliporeSigma Acquires BioControl to Strengthen Position in Food Safety Testing | | |
| 02 |
| |
| | 02/28/2017 | 01:00 PM | | FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review | | |
| | 02/09/2017 | 11:00 AM | | Cladribine Tablets Significantly Reduced Brain Atrophy in Patients with Multiple Sclerosis | | |
| | 02/08/2017 | 03:00 PM | | North American Businesses of Merck KGaA, Darmstadt, Germany Certified as 2017 Top Employer | | |
| | 02/02/2017 | 10:30 AM | | Merck KGaA, Darmstadt, Germany, appoints Anke Schenkel as Head of Group Controlling & Risk Management | | |
| 03 |
| |
| | 03/30/2017 | 08:00 AM | | Merck KGaA, Darmstadt, Germany Advances R&D Strategy through Unique Development Model with Avillion for Anti IL-17 A/F Nanobody | | |
| | 03/23/2017 | 10:30 PM | | FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma | | |
| | 03/22/2017 | 10:00 AM | | “Bold & Vibrant”: Merck KGaA, Darmstadt, Germany, Presents Innovations at the European Coatings Show 2017 | | |
| | 03/21/2017 | 01:00 PM | | MilliporeSigma Introduces Mobius® MyWay Portfolio for Customized Single-use Assemblies | | |
| | 03/16/2017 | 10:00 AM | | Merck KGaA, Darmstadt, Germany, Presents Special Effect Products and Concepts at in-cosmetics 2017 | | |
| | 03/09/2017 | 07:00 AM | | Merck KGaA, Darmstadt, Germany, Generates Record Sales and Continues to Grow Profitably in 2016 | | |
| | 03/06/2017 | 06:00 PM | | MilliporeSigma Advances Lab Water Purification Technology with Milli-Q® IQ 7000 System | | |
| | 03/02/2017 | 02:45 PM | | Allergopharma Opens new Biopharmaceutical Production in Reinbek | | |
| | 03/01/2017 | 09:00 AM | | Merck KGaA, Darmstadt, Germany, Named One of the Global Top Employers in 2017 | | |